• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌手术治疗质量控制中的盆腔及宫旁淋巴结

Pelvic and parametrial lymph nodes in the quality control of the surgical treatment of cervical cancer.

作者信息

Girardi F, Pickel H, Winter R

机构信息

Department of Obstetrics and Gynecology, University of Graz, Austria.

出版信息

Gynecol Oncol. 1993 Sep;50(3):330-3. doi: 10.1006/gyno.1993.1220.

DOI:10.1006/gyno.1993.1220
PMID:8406196
Abstract

Between 1971 and 1989 a total of 420 patients underwent radical abdominal hysterectomy with pelvic lymphadenectomy at our hospital for stage Ib, IIa, or IIb cervical cancer. The entire lymph node material was processed in serial sections and stained with hematoxylin and eosin. Lymph nodes were counted and the sizes of metastases measured. The entire surgical specimen was fixed as a whole with the parametria spread out. The size of the tumor was measured by morphometry. Cases treated between 1971 and 1979 were compared with those treated between 1980 and 1989. The median number of pelvic lymph nodes removed per patient was 24 between 1971 and 1979 and 35 between 1980 and 1989 (P = 0.0001). Significantly more nodes were removed at each node group (P = 0.01). Between 1971 and 1979 no common iliac nodes were obtained in 56 patients and no left common iliac nodes in 74 patients, compared to only 1 and 6 patients, respectively, between 1980 and 1989. The rate of patients with positive lymph nodes was 33% (63/195) between 1971 and 1979 and 55% (101/225) between 1981 and 1989 (P = 0.008). In the first study period the median number of parametrial lymph nodes was 2 compared to 3 in the second period. The rate of patients with positive parametrial lymph nodes increased from 15 to 24% (P = 0.027). The results of this review indicate that exacting morphologic processing of the entire lymphatic tissue obtained at surgery permits accurate postoperative staging and assessment of risk factors for decisions on adjuvant treatment. Histologic evaluation objectifies the radicality of the procedure and is useful in the quality control of the surgical treatment of cervical cancer.

摘要

1971年至1989年间,我院共有420例Ib期、IIa期或IIb期宫颈癌患者接受了根治性腹式子宫切除术及盆腔淋巴结清扫术。所有淋巴结组织均制成连续切片,并用苏木精和伊红染色。对淋巴结进行计数并测量转移灶大小。整个手术标本连同展开的宫旁组织一起整块固定。通过形态测量法测量肿瘤大小。将1971年至1979年期间治疗的病例与1980年至1989年期间治疗的病例进行比较。1971年至1979年期间,每位患者切除的盆腔淋巴结中位数为24个,1980年至1989年期间为35个(P = 0.0001)。每个淋巴结组切除的淋巴结明显更多(P = 0.01)。1971年至1979年间,56例患者未获取到髂总淋巴结,74例患者未获取到左髂总淋巴结,而1980年至1989年间分别仅有1例和6例患者未获取到。1971年至1979年间淋巴结阳性患者的比例为33%(63/195),1981年至1989年间为55%(101/225)(P = 0.008)。在第一个研究期间,宫旁淋巴结的中位数为2个,而在第二个期间为3个。宫旁淋巴结阳性患者的比例从15%增至24%(P = 0.027)。本综述结果表明,对手术获取的整个淋巴组织进行严格的形态学处理有助于准确的术后分期以及评估辅助治疗决策的风险因素。组织学评估可客观体现手术的根治程度,有助于宫颈癌手术治疗的质量控制。

相似文献

1
Pelvic and parametrial lymph nodes in the quality control of the surgical treatment of cervical cancer.宫颈癌手术治疗质量控制中的盆腔及宫旁淋巴结
Gynecol Oncol. 1993 Sep;50(3):330-3. doi: 10.1006/gyno.1993.1220.
2
Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.早期宫颈癌:基于彻底的子宫旁组织切除术和巨检研究对淋巴结受累自然病程的重新定义。
Cancer. 2000 May 15;88(10):2267-74.
3
Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.根治性膀胱切除术和扩大盆腔淋巴结清扫术:仅接受手术治疗的髂总血管分叉以上淋巴结转移患者的生存率。
J Urol. 2007 Oct;178(4 Pt 1):1218-23; discussion 1223-4. doi: 10.1016/j.juro.2007.05.160. Epub 2007 Aug 14.
4
The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer.盆腔淋巴结数量在宫颈癌根治性子宫切除术中的质量控制及预后情况
Eur J Surg Oncol. 2007 Mar;33(2):216-21. doi: 10.1016/j.ejso.2006.09.037. Epub 2006 Nov 13.
5
The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.早期宫颈癌患者行根治性子宫切除术后放疗的预后因素。
Gynecol Oncol. 1999 Dec;75(3):328-33. doi: 10.1006/gyno.1999.5527.
6
High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.IB期、IIA期和IIB期宫颈癌患者根治性子宫切除术后及术后盆腔放疗后淋巴结阳性的高危组。
Gynecol Oncol. 2000 May;77(2):305-9. doi: 10.1006/gyno.2000.5788.
7
Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy.宫颈癌的淋巴转移:一项基于225例根治性子宫切除术及系统性盆腔和主动脉旁淋巴结清扫术的解剖学与病理学研究
Gynecol Oncol. 1996 Jul;62(1):19-24. doi: 10.1006/gyno.1996.0184.
8
[Lymphatic mapping and parametrial lymph nodes identification in patients with early stage cervical cancer].[早期宫颈癌患者的淋巴绘图及宫旁淋巴结识别]
Zhonghua Fu Chan Ke Za Zhi. 2006 Sep;41(9):608-11.
9
Pattern of lymph node metastasis and the optimal extent of pelvic lymphadenectomy in FIGO stage IB cervical cancer.FIGO 分期 IB 期宫颈癌的淋巴结转移模式及盆腔淋巴结清扫的最佳范围
J Obstet Gynaecol Res. 2007 Jun;33(3):288-93. doi: 10.1111/j.1447-0756.2007.00526.x.
10
The case for completing the lymphadenectomy when positive lymph nodes are found during radical hysterectomy for cervical carcinoma.在宫颈癌根治性子宫切除术中发现阳性淋巴结时完成淋巴结清扫术的理由。
Acta Obstet Gynecol Scand. 2000 Jan;79(1):72-6.

引用本文的文献

1
What is paracervical lymphadenectomy?什么是宫颈旁淋巴结切除术?
Gynecol Oncol Rep. 2021 Nov 18;38:100891. doi: 10.1016/j.gore.2021.100891. eCollection 2021 Nov.
2
Potential prognostic factors in progression-free survival for patients with cervical cancer.宫颈癌无进展生存的潜在预后因素。
BMC Cancer. 2021 May 10;21(1):531. doi: 10.1186/s12885-021-08243-3.
3
Separate lateral parametrial lymph node dissection improves detection rate of parametrial lymph node metastasis in early-stage cervical cancer: 10-year clinical evaluation in a single center in China.
单独的侧方宫旁淋巴结清扫术可提高早期宫颈癌宫旁淋巴结转移的检出率:中国单中心10年临床评估
Chin J Cancer Res. 2020 Dec 31;32(6):804-814. doi: 10.21147/j.issn.1000-9604.2020.06.08.
4
[Recommendations for the handling and oncologic pathology report of lymph node specimens submitted for evaluation of metastatic disease in gynecologic malignancies].[关于提交用于评估妇科恶性肿瘤转移性疾病的淋巴结标本的处理及肿瘤病理学报告的建议]
Pathologe. 2005 Jul;26(4):266-72. doi: 10.1007/s00292-005-0764-3.